Kevin Patrick Moran - 01 Mar 2025 Form 4 Insider Report for Vanda Pharmaceuticals Inc. (VNDA)

Signature
/s/ Kevin Patrick Moran
Issuer symbol
VNDA
Transactions as of
01 Mar 2025
Net transactions value
-$128,239
Form type
4
Filing time
04 Mar 2025, 16:45:27 UTC
Previous filing
24 Feb 2025
Next filing
19 Feb 2026

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VNDA Common Stock Tax liability $128,239 -26,941 -7.6% $4.76 328,822 01 Mar 2025 Direct F1
holding VNDA Common Stock 635 01 Mar 2025 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs.